493 related articles for article (PubMed ID: 27401332)
1. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study.
Ikuyama Y; Ushiki A; Kosaka M; Akahane J; Mukai Y; Araki T; Kitaguchi Y; Tateishi K; Urushihata K; Yasuo M; Yamamoto H; Hanaoka M
BMC Pulm Med; 2020 May; 20(1):144. PubMed ID: 32434532
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
5. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Kishaba T; Tamaki H; Shimaoka Y; Fukuyama H; Yamashiro S
Lung; 2014 Feb; 192(1):141-9. PubMed ID: 24221341
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
[TBL] [Abstract][Full Text] [Related]
8. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park SW; Park MS
Respir Res; 2016 Oct; 17(1):131. PubMed ID: 27756398
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
[TBL] [Abstract][Full Text] [Related]
11. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
[TBL] [Abstract][Full Text] [Related]
12. Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia.
Takei R; Arita M; Kumagai S; Ito Y; Noyama M; Tokioka F; Ishida T
BMC Pulm Med; 2017 Apr; 17(1):67. PubMed ID: 28427425
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis.
Lee JS; Song JW; Wolters PJ; Elicker BM; King TE; Kim DS; Collard HR
Eur Respir J; 2012 Feb; 39(2):352-8. PubMed ID: 22183478
[TBL] [Abstract][Full Text] [Related]
14. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS
Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis.
Barlo NP; van Moorsel CH; Ruven HJ; Zanen P; van den Bosch JM; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):155-61. PubMed ID: 20560296
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis.
Horita N; Akahane M; Okada Y; Kobayashi Y; Arai T; Amano I; Takezawa T; To M; To Y
Intern Med; 2011; 50(3):189-95. PubMed ID: 21297319
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
18. Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
Homma S; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Kondoh Y
Respir Investig; 2022 Nov; 60(6):798-805. PubMed ID: 36068159
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study.
Abe M; Tsushima K; Ishii D; Shikano K; Yoshioka K; Sakayori M; Suzuki M; Hirasawa Y; Ishiwata T; Kawasaki T; Ikari J; Terada J; Tatsumi K
Adv Respir Med; 2021; 89(2):101-109. PubMed ID: 33881153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
